April 29, 2020 / 5:20 PM / a month ago

BRIEF-NIH Clinical Trial Shows Remdesivir Accelerates Recovery From Advanced Covid-19

April 29 (Reuters) - NIH:

* NIH CLINICAL TRIAL SHOWS REMDESIVIR ACCELERATES RECOVERY FROM ADVANCED COVID-19

* NIH - PRELIMINARY RESULTS INDICATE THAT PATIENTS WHO RECEIVED REMDESIVIR HAD A 31% FASTER TIME TO RECOVERY THAN THOSE WHO RECEIVED PLACEBO

* NIH - INDEPENDENT DATA AND SAFETY MONITORING BOARD NOTED THAT REMDESIVIR WAS BETTER THAN PLACEBO FROM PERSPECTIVE OF PRIMARY ENDPOINT IN TRIAL

* NIH- PRELIM RESULTS SUGGESTED A SURVIVAL BENEFIT, WITH A MORTALITY RATE OF 8.0% FOR GROUP RECEIVING REMDESIVIR VERSUS 11.6% FOR PLACEBO GROUP

* NIH - NIAID WILL ALSO PROVIDE AN UPDATE ON PLANS FOR ACTT TRIAL MOVING FORWARD

* NIH - MEDIAN TIME TO RECOVERY WAS 11 DAYS FOR PATIENTS TREATED WITH REMDESIVIR COMPARED WITH 15 DAYS FOR THOSE WHO RECEIVED PLACEBO Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below